How to Prepare a Norepinephrine Drip
Standard Adult Concentration
Add 4 mg of norepinephrine to 250 mL of D5W to yield a concentration of 16 μg/mL, which is the standard adult preparation. 1
- This concentration is stable for seven days at room temperature under ambient light in either D5W or normal saline 2
- Alternative concentration: Add 1 mg of norepinephrine to 100 mL of saline to create 10 μg/mL concentration 1
Initial Dosing and Administration
Start the infusion at 0.5 mg/h (approximately 8-12 mcg/min or 0.1-0.5 mcg/kg/min) via continuous IV infusion, preferably through central venous access. 1
- For weight-based dosing: 0.02-0.1 mcg/kg/min is the typical starting range 1
- Titrate every 4 hours by 0.5 mg/h increments to a maximum of 3 mg/h 1
- Target mean arterial pressure (MAP) of 65 mmHg for most patients 1
Critical Pre-Administration Requirements
Administer a minimum 30 mL/kg crystalloid bolus before or concurrent with norepinephrine initiation to prevent severe organ hypoperfusion from vasoconstriction in hypovolemic patients. 1
- Use balanced crystalloids (lactated Ringer's or Plasma-Lyte) preferentially over normal saline 1
- In severe hypotension (systolic <70 mmHg), start norepinephrine as an emergency measure while fluid resuscitation continues 1
Administration Route and Line Selection
Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis. 1
- If central access is unavailable or delayed, peripheral IV or intraosseous administration can be used temporarily 1
- Place an arterial catheter as soon as practical for continuous blood pressure monitoring 1
- Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions in the IV line, as catecholamines are inactivated in alkaline solutions. 1
Monitoring Protocol
Monitor blood pressure and heart rate every 5-15 minutes during initial titration. 1
- Assess tissue perfusion markers: lactate clearance, urine output >50 mL/h, mental status, capillary refill 1
- Watch for signs of excessive vasoconstriction: cold extremities, decreased urine output 1
- Monitor for potential side effects including hypertension, arrhythmias, and tissue ischemia 1
Extravasation Management
If extravasation occurs, immediately infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline intradermally at the site to prevent tissue necrosis. 1
- Pediatric dose: 0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride 1
- This must be done as soon as possible to prevent tissue death and sloughing 1
Escalation Strategy for Refractory Hypotension
When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, add vasopressin 0.03-0.04 units/min as second-line therapy. 1
- Do not increase vasopressin above 0.03-0.04 units/min; reserve higher doses for salvage therapy only 1
- Epinephrine 0.1-0.5 mcg/kg/min can be added if needed 1
- For persistent hypoperfusion despite adequate vasopressors, add dobutamine up to 20 mcg/kg/min, particularly with myocardial dysfunction 1
Pediatric Preparation and Dosing
For pediatric patients, use the "Rule of 6": multiply 0.6 × body weight (kg) to get the number of milligrams, then dilute to 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min. 1
- Starting dose: 0.1 mcg/kg/min, titrated to desired clinical effect 1
- Typical range: 0.1-1.0 mcg/kg/min 1
- Maximum doses up to 5 mcg/kg/min may be necessary in some children 1
Common Pitfalls to Avoid
- Never start norepinephrine without adequate fluid resuscitation, as vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure 1
- Do not use dopamine as first-line agent, as it is associated with higher mortality and more arrhythmias compared to norepinephrine 1
- Do not use low-dose dopamine for "renal protection", as it provides no benefit 1
- Do not use phenylephrine as first-line therapy, as it may raise blood pressure while worsening tissue perfusion 1
Special Clinical Scenarios
For anaphylaxis not responding to epinephrine and volume resuscitation, use the alternative 1:100,000 solution (1 mg in 100 mL saline) administered at 30-100 mL/h (5-15 mcg/min). 1